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Abstract
The method of fluorescence lifetime imaging microscopy (FLIM) is a quantitative approach that
can be used to detect Förster Resonance Energy Transfer (FRET). The use of FLIM to measure the
FRET that results from the interactions between proteins labeled with fluorescent proteins (FPs)
inside living cells provides a non-invasive method for mapping interactomes. Here, the use of the
phasor plot method to analyze frequency domain (FD) FLIM measurements is described, and
measurements obtained from cells producing the 'FRET standard' fusion proteins are used to
validate the FLIM system for FRET measurements. The FLIM FRET approach is then used to
measure both homologous and heterologous protein-protein interactions (PPI) involving the
CCAAT/enhancer-binding protein alpha (C/EBPα). C/EBPα is a transcription factor that controls
cell differentiation, and localizes to heterochromatin where it interacts with the heterochromatin
protein 1 alpha (HP1α). The FLIM-FRET method is used to quantify the homologous interactions
between the FP-labeled basic leucine zipper (BZip) domain of C/EBPα. Then the heterologous
interactions between the C/EBPa BZip domain and HP1a are quantified using the FRET-FLIM
method. The results demonstrate that the basic region and leucine zipper (BZip) domain of C/
EBPα is sufficient for the interaction with HP1α in regions of heterochromatin.
Keywords
fluorescence lifetime imaging microscopy (FLIM); Förster resonance energy transfer (FRET)
microscopy; fluorescent proteins (FPs); protein-protein interactions (PPI)
1. Introduction
Cellular proteins function as components in larger protein complexes that are transiently
assembled to mediate specific processes. The interconnected networks of protein-protein
interactions (PPI) that form these complexes have dynamic properties and are typically
localized to specific regions within the cell, reflecting the activity of the complex. The
mapping of PPI networks in mammalian cells, known as interactomes, is a critical step
towards understanding human disease processes. What is more, the mapping of interactomes
provides the insights necessary for the development of therapeutic strategies designed to
disrupt specific PPI linked to disease [1]. The high-throughput screening methods most often
used for mapping PPI are yeast two-hybrid and co-affinity purification assays followed by
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mass spectrometry [2–4]. The information obtained from these screening methods is
supplemented with information from curated interaction datasets derived from the literature
[5], and from predictive computer algorithms [6].
A problem with these approaches is that it is difficult to separate biologically significant PPI
from random interactions that may be detected by yeast two-hybrid, or non-specific
interactions that can be detected in the disrupted cell preparations used for co-affinity
purification. Protein interactions within cells are very dependent on the context in which
they occur, and are dynamic and transient in nature. Therefore, some of the interactions
mapped by these screening techniques may not be biologically relevant, and these
approaches may fail to detect transient, but meaningful interactions that occur in specific
cell-types. Furthermore, these approaches do not identify dynamic PPI that may only occur
in discrete subcellular compartments. Hence, the interactome map developed by high
throughput approaches still requires verification by many different types of cellular assays.
Most importantly, since many PPI are dependent upon the association with specific cellular
components, verification of these types of interactions may only be possible within the
context of the intact cell. Therefore, the development of non-invasive quantitative imaging
techniques to visualize the protein interactions inside living cells is necessary for mapping
the interactome. Here, a non-invasive imaging approach that enables the detection of PPI
inside living cells is described. The approach involves the use of frequency domain
fluorescence lifetime imaging microscopy (FD FLIM) to detect the Förster resonance energy
transfer (FRET) that results from the interactions between proteins labeled with fluorescent
proteins (FPs) inside living cells.
2. Materials and Methods
2.1. Expression plasmids and purified fluorescent proteins
The cDNA for Venus was obtained from Dr. Atsushi Miyawaki (RIKEN, Japan) [7]. The
plasmids encoding the monomeric (m)Cerulean, mCerulean3, mTurquoise, and
mTurquoise2 proteins were obtained from Dr. Michael Davidson (FSU, Tallahassee, FL).
The mCerulean3 [8], mTurquoise [9], and mTurquoise2 [10] are engineered variants of
mCerulean [11] with improved photophysical behavior. Standard recombinant DNA
methods were used to generate the plasmids encoding the FRET standard proteins consisting
of mCerulean3 linked to mVenus. Similar approaches were also used to generate the FPs
linked in-frame to the sequence for the indicated proteins. All plasmid inserts were
confirmed by direct sequencing. The purified FPs were provided by Dr. Michael Davidson
and Paula Cranfill (FSU, Tallahassee, FL). The 6xHis-tagged proteins were grown in
bacteria, which were disrupted by sonication, and the supernatant was recovered by
centrifugation. The supernatant was mixed with Talon resin and eluted. The purified FPs
were concentrated using an Amicon Ultra centrifugal filter (Millipore) in PBS (pH 7.4).
About 100 µl of the concentrated solution was added to an eight-chambered coverglass for
the FLIM measurements described below.
2.2. Tissue culture and transfection
The mouse pituitary GHFT1 cells are maintained in monolayer culture and harvested at 80%
confluence [12]. The cells are washed with phosphate buffered saline (PBS), treated briefly
with trypsin (0.05% in 0.53 mM EDTA), and recovered by centrifugation in culture medium
containing serum. The cells are washed two times by centrifugation in Dulbecco’s calcium-
magnesium free PBS and resuspended in Dulbecco’s calcium-magnesium free PBS with
0.1% glucose and 0.1 ng/ml BioBrene Plus (Applied Biosystems, Inc.) at a final
concentration of approximately 1x107 cells per ml. Exactly 400 µl of the cell suspension is
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transferred to each 0.2 cm gap electroporation cuvette containing the plasmid DNA(s). For
FRET studies involving independently expressed donor- and acceptor-labeled proteins, the
amount of plasmid DNA encoding the donor- and the acceptor-labeled proteins was adjusted
to favor acceptor expression, using a total of 10 µg of purified plasmid DNA per cuvette.
The contents of the cuvettes are gently mixed, and then pulsed with 200 volts at a
capacitance of 1200 microfarads in a BTX ECM 830 electroporator (Harvard Apparatus),
yielding pulse durations of about 10 ms. The cells are immediately recovered from the
cuvette and diluted in phenol red-free tissue culture medium containing serum. The
suspension is transferred to sterile two well-chambered coverglass (Lab-Tek II, Thermo
Scientific), which are placed in an incubator (37°C and 5% CO2) prior to FLIM the
following day.
2.3. FD FLIM measurements
The fluorescence lifetime measurements are made using the ISS Alba FastFLIM system
(ISS Inc., Champagne, IL) coupled to an Olympus IX71 microscope equipped with a 60 X,
1.2 numerical aperture water-immersion objective lens. A Pathology Devices (Pathology
Devices, Inc.) stage-top environmental control system maintains the temperature at 36° C
and CO2 at 5%. For FD FLIM using the cyan and yellow FPs the 5 mW 448 nm diode laser
is modulated by the Alba FastFLIM system at a fundamental frequency of 10 MHz, with
additional measurements at up to 13 sinusoidal harmonics (10–140 MHz). The modulated
laser is coupled to the confocal scanning system, which is controlled by the VistaVision
software (Build 143, ISS Inc., Champagne, IL). The fluorescence signals emitted from the
specimen are routed by a 495 nm long pass beam splitter through the 530/43 nm (acceptor
emission) and 480/40 (donor emission) band-pass emission filters, and the signals are
detected using two identical avalanche photodiodes (APD). The phase delays and
modulation ratios of the emission relative to the excitation are measured at each pixel of an
image for each frequency.
The system is calibrated with 50 mM Coumarin 6 dissolved in ethanol (reference lifetime
2.5 ns; http://www.iss.com/resources/reference/data_tables/LifetimeDataFluorophores.html).
A chambered coverglass with the dye sample is illuminated at sufficient laser power to
achieve approximately 100,000 counts per second in the donor emission channel, and frame
averaging is used to calibrate the software using the 2.5 ns reference sample. To verify the
calibration, lifetime measurements are made of a second reference standard, 10 mM HPTS
(8 - hydroxypyrene - 1,3,6 - trisulfonic acid from Santa Cruz Biotechnology, Inc.) dissolved
in phosphate buffer (PB) pH 7.8 (reference lifetime of 5.3 ns [13]). The distribution of the
lifetimes for all the pixels in the image is determined using the phasor (polar) plot method
[14–19].
For live-cell FD FLIM measurements from transfected cells producing the FP-labeled
proteins, the cells are first identified by epifluorescence microscopy. For FD FLIM
measurement using the confocal laser scanning system and APD detectors, it is important to
adjust the laser power to achieve a similar count rate in the donor emission channel to that
used for calibration of the system. Frame averaging is used to acquire a 256 × 256 pixel
lifetime image with about 200 peak counts per pixel. This typically requires about 45
seconds, and it is important to adjust laser power so that there is no significant
photobleaching of the samples during image acquisition. The FLIM images are analyzed
with the VistaVision software by selecting regions of interest (ROI, typically 1–2 µm2) with
average intensity > 75 counts. The most accurate lifetime determinations are obtained by
analyzing the first 12 frequencies (10 – 120 MHz). The quality of the fit is judged by the
reduced chi-square values for the Weber plots of phase delay and modulation ratio vs.
frequency. The ratio of the donor lifetimes determined in the absence (τD) and in the
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presence of the acceptor (τDA) provides a direct estimate of FRET efficiency (EFRET) by Eq.
1:
[1]
For intermolecular FRET measurements from independently expressed proteins, the ratio of
the acceptor- to the donor-labeled proteins influences the EFRET [19, 20]. The two-channel
imaging system used here allows simultaneous measurement of the intensity of the donor
emission (ID) and the intensity of the acceptor emission (IA), which are detected by the two
identical APDs. The mean intensity in both the donor and the acceptor channels are
measured for each ROI, and this serves as a proxy for the ratio of the acceptor- to the donor-
labeled proteins in each ROI. The FRET efficiency is calculated using Eq. 1 from the
lifetime of the quenched donor determined for each ROI, and the averaged results for each
cell are plotted as a function of the measured acceptor to donor (IA/ID) ratio. The data are
fitted by a nonlinear regression for saturation binding constraining the background to zero
using the GraphPad Prism software.
3. Results and discussion
3.1. Lifetime measurement of purified FPs alone and in mixtures
The FD lifetime images are analyzed using the phasor plot method, which was originally
developed as a way to analyze transient responses to repetitive experimental perturbations,
and can be applied to any system with frequency characteristics [15, 16]. The phasor plot is
a simple geometric representation of the relative modulation ratio (M) and the phase delay
(ϕ) of the emission signal measured at every pixel in an image. The frequency
characteristics of the emission signal from each image pixel is plotted on a polar coordinate
system using a vector with length determined by the modulation ratio and angle determined
by the phase delay. The phase delay and modulation ratio are related to the lifetime (τ) at
particular frequency ω as:
For a single exponential decay, the relationship M = cos ϕ describes a vector with an
endpoint that falls on a universal semicircle with a radius of 0.5 that is centered at (0.5, 0) on
the polar coordinate system. The semicircle is universal in the sense that the lifetime
distribution for any species with a single-exponential decay will fall directly on the
semicircle irrespective of the lifetime or modulation frequency [15, 16]. The X and Y
intercepts of the vector correspond to the polar coordinates G = M cos ϕ and S = M sin ϕ,
with longer lifetimes to the left (see Fig. 1). It is important to emphasize that this is a direct
measurement of the fluorescence lifetime of the fluorophores within a specimen, and does
not require fitting to determine the time decay parameters of the separate components [15–
19].
To demonstrate the analysis of fluorescence lifetime measurements using the phasor plot
method, FD FLIM was used to acquire images from solutions containing either the purified
mCerulean or mTurquoise2 FPs, or mixtures of the two FPs. Turquoise2 is an engineered
variant of Cerulean that retains the same spectral characteristics, but has a markedly
improved quantum yield (0.93 vs. 0.49 for Cerulean) [10]. A direct consequence of the
increased quantum yield of mTurquoise2 is a longer fluorescence lifetime compared to
mCerulean [21]. The acquisition and analysis of FD FLIM data are demonstrated here using
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the Weber plot (Fig. 1A) of the phase delay and modulation ratio for the purified mCerulean
or mTurquoise2 samples measured at multiple frequencies. A phasor plot is then generated
from the data obtained at 30 MHz, and this clearly shows the distinct lifetime distributions
for mCerulean3 and mTurquoise2, with the distribution for the longer-lifetime mTurquoise2
shifted to the left along the universal semicircle (Fig. 1B).
The phasor analysis also provides important information about the photophysical behavior
of the purified FPs. The lifetime distribution for mTurquoise2 lies slightly above the
universal semicircle (Fig. 1B), which can be an indication of artifacts interfering with the
measurements, including photobleaching events during acquisition [15]. Our data suggest
that there is a small fraction of Turquoise2 that is sensitive to photobleaching. The analysis
of data demonstrates that Turquoise2 is best fit by a single-exponential lifetime decay of 4.5
ns (Table 1). In contrast, the phasor plot for purified mCerulean falls inside the universal
semicircle, and this is diagnostic for the presence of more than one lifetime component (Fig.
1B). The analysis of the data acquired for mCerulean shows it is best fit by a two-component
decay, with lifetimes of 4.8 ns (34%) and 2.1 ns (66%), resulting in an intensity-weighted
average lifetime of 3.1 ns (Table 1).
The distinct locations of the lifetime distributions for these two spectrally identical FPs on
the polar coordinate system not only clearly identifies the spectrally identical species, but
importantly, can also determine their relative contributions in mixtures. This is illustrated in
the phasor analysis of mixtures of the purified mTurquoise2 and mCerulean (Fig. 1C). The
lifetime distributions for each mixture are determined solely from the phase delay and
modulation ratio of the emission signal from each image pixel. The lifetimes for the
mixtures of purified proteins, determined from the phasor analysis are presented in Table 2.
The locations of the lifetime distributions for each mixture on the phasor plot fall on a
straight line that connects the distributions for the two different pure species, and the
position on the line identifies the relative fraction of each lifetime component [15].
Together, these results demonstrate how the phasor plot analysis enables the separation of
different lifetime components from FD FLIM images without the need for fitting algorithms.
3.2. FRET-FLIM measurements from FRET standard proteins
Next, the phasor analysis is applied to FD FLIM measurements from living cells expressing
the “FRET standard” fusion proteins. The FRET standard approach that was developed by
the Vogel laboratory provides a straightforward method to verify both the biological model,
and the imaging system used for FRET measurements [22,23]. The original FRET standard
fusion proteins consist of mCerulean linked to mVenus. However, since mCerulean has
more than one lifetime (Fig. 1B, Table 1), it is replaced here by the mCerulean3 variant. The
mCerulean3 FP has reduced photoswitching behavior and improved photostability compared
to mCerulean, and the purified protein has a single component lifetime of 4.0 ns (Table 1)
[8]. The plasmid encoding the fusion protein consisting of mCerulean3 coupled to mVenus
through the five-amino acid (5aa) linker serves as a high FRET efficiency standard. Since
the fluorescence lifetime can be very sensitive to the local environment of the donor
fluorophore, a similar plasmid that encodes the mCerulean3 linked to mutant variant of
mVenus, called Amber, was also generated. The mutation converts the chromophore
tyrosine to a cysteine producing a non-fluorescent form of Venus that folds correctly, but
does not act as a FRET acceptor [24]. Thus, the local environment for Cerulean3 is same for
the Amber and Venus constructs, with the Cerulean3-5aa-Amber fusion protein providing an
accurate measurement of the unquenched donor lifetime. Additionally, a fusion protein
consisting of mCerulean3 linked to mVenus through the 229-amino acid tumor necrosis
factor receptor associated factor (TRAF) domain (Cerulean3-TRAF-Venus) is used to
provide a low FRET efficiency standard [23].
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The composite phasor plot in Fig. 2 compares the unquenched and quenched donor lifetimes
for the different Cerulean3 FRET standard fusion proteins expressed in living cells. The
intensity images obtained from each of the cells expressing the different FRET standard
fusion proteins are shown in the right panels of Fig. 2, with the ROI that was used to
determine the average lifetime indicated. For the cell expressing Cerulean3-5aa-Amber (Fig.
2A), the unquenched donor lifetime was 3.96 ns, and was best fit as a single-component
decay. The donor lifetime for the Cerulean3-TRAF-Venus fusion protein, determined in the
indicated ROI (Fig. 2B) was 3.68 ns, corresponding to a FRET efficiency (EFRET) of 7%
(determined by Eq. 1). In contrast, the lifetime distribution for the cell expressing
Cerulean3-5aa-Venus (Fig. 2C) clearly shows the quenched donor lifetime for this high
FRET standard, and falls inside the semicircle, indicative of the multi-component lifetime.
The multi-component lifetime for this genetic FRET construct comprised of one donor
linked to one acceptor arises because the FPs rotate slowly relative to their fluorescence
lifetime. Since there will be a negligible change in the dipole orientation during the excited
state lifetime, little averaging will occur. Monte-Carlo simulations were recently used to
demonstrate that the slow rotation of the FPs has the potential to give rise to a bimodal
distribution of efficiencies in FRET experiments [24]. When analyzing the multi-exponential
lifetimes that result from the linked FRET standard protein, the energy transfer efficiency is
determined using the amplitude-weighted lifetime [21]. The amplitude-weighted lifetime for
Cerulean3-5aa-Venus is 2.36 ns (Fig. 2C), which corresponds to an EFRET of 40%.
3.3. Measuring the homologous interactions of the C/EBPα BZip domain by FRET-FLIM
The FD FLIM method is next applied to the detection of the homologous interactions
between the basic region leucine zipper (BZip) domains of the transcription factor C/EBPα.
The C/EBP transcription factors bind to DNA as obligate dimers through interactions
between their BZip domains [25]. These transcription factors localize to regions of
centromeric heterochromatin by binding to consensus DNA elements in repeated α-satellite
sequences that are readily detected in mouse cells [26, 27]. Here, mouse pituitary GHFT1
cells expressing the C/EBPα BZip domain labeled with mTurquoise only (donor) or in
combination with the BZip domain fused mVenus (acceptor) are imaged using FD FLIM
(see Fig. 3A). The purified mTurquoise protein has a single component lifetime of 4.1 ns
(Table 1), and behaves similarly to Cerulean3 as a donor fluorophore (Day and Davidson, in
preparation). Representative intensity images of the nucleus of a cell that expressed only the
mTurquoise BZip domain protein (donor alone, Fig. 3B), or the nucleus of a cell that co-
expressed the mTurquoise- and Venus-BZip domain proteins (donor + acceptor, Fig. 3C) are
shown. The areas of high fluorescence signal in the intensity images result from the
localization of the BZip proteins to regions of centromeric heterochromatin in these mouse
cells. The lifetime map in Fig. 3B depicts the unquenched donor lifetimes in regions of
heterochromatin for mTurquoise-BZip domain expressed alone, indicated by warmer colors
on the lookup table (LUT). In contrast, the quenched lifetimes of the Turquoise-BZip
domain co-expressed with the Venus-labeled BZip domain, indicated by cooler colors on the
LUT, are clearly seen in Fig. 3C.
The quantification of intermolecular FRET between labeled proteins independently
produced in living cells requires several important considerations, illustrated here using the
homologous interactions between the BZip domain proteins. First, the unquenched donor
lifetime must be determined for the donor labeled proteins that are localized to the specific
subcellular region. This is important since lifetime can be influenced by local environmental
factors that may alter the excited state of the fluorophore. Here, the unquenched lifetime of
the mTurquoise-BZip fusion protein bound to heterochromatin was measured in multiple
different ROI within the nuclei of separate cells. The intensity images shown in Fig. 3B and
3C illustrate the areas of centromeric heterochromatin that are easily identified and selected
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as individual ROI. For the measurement of unquenched donor lifetimes, separate regions are
selected within each cell nucleus to determine the average lifetime for that cell. The
measurements were then repeated for ten different cells, yielding an average lifetime for the
mTurquoise-BZip proteins bound to heterochromatin of 3.84 ± 0.13 ns.
There are two important considerations regarding the donor-alone measurements. First, the
FLIM analysis is greatly simplified when the donor FP has a single component lifetime, and,
unlike mCerulean, the lifetime decay of mTurquoise is best fit to a single component (Table
1). Second, the donor-labeled proteins are interacting and forming dimers, so there will be
energy migration FRET (homo-FRET) between the identical fluorophores. The homo-FRET
process generally does not change the donor lifetime [28], but it was shown to shorten the
lifetime of Cerulean [29]. The lifetime of mTurquoise (a freely diffusing monomer)
measured in the cytoplasm of multiple cells was 3.82 ns ± 0.04, so it appears that homo-
FRET is not quenching the mTurquoise-BZip proteins bound to heterochromatin.
The measurement of intermolecular FRET between the independently produced donor- and
acceptor-labeled proteins requires additional considerations. Because the donor- and
acceptor-labeled proteins are encoded by separate plasmids, each of the co-transfected cells
will express a different ratio of the labeled proteins. The donor-to-acceptor ratio influences
the EFRET, since cells expressing predominately donor-labeled proteins will have little or no
FRET, while cells with an excess of acceptor will have potentially high FRET [19, 20]. The
lifetime imaging microscope used here is a two-channel system that simultaneously directs
the emission signals through the donor (480/40 nm) and acceptor (530/43 nm) channels to
the two identical APD detectors. There is no bleedthrough of the Venus (acceptor) emission
signal into the donor channel, so measurement of the quenched donor lifetime (τDA) is all
that is required for the determination of EFRET. However, because the donor-to-acceptor
ratio varies from cell to cell, it is necessary to determine the relative level of the donor- and
acceptor-labeled proteins for each ROI that is selected for donor lifetime measurements. The
mean intensity in both the donor (ID) and the acceptor (IA) channels are measured for each
of the ROI used for lifetime determination, and this serves as a proxy for the ratio of the
acceptor- to the donor-labeled proteins in each ROI, providing a straightforward and
consistent approach to qualitatively determine the relative expression of the donor and
acceptor labeled proteins. The measurement of the quenched donor lifetime in the same ROI
allows the determination of EFRET (Eq. 1) at a particular (IA/ID) ratio.
The results in Fig. 3D show the relationship of the EFRET determined by fluorescence
lifetime for the mTurquoise-BZip domain co-expressed with the mVenus-BZip domain
protein when plotted as a function of the different IA/ID ratios. The average IA/ID ratio (±
SD) and the average EFRET (± SD) are represented for multiple cells across a range of IA/ID
(Fig. 3D). As the acceptor to the donor ratio is increased, there is more quenching of the
mTurquoise-BZip donor signal (detected in the 480/40 nm donor channel). The highest
EFRET values (lowest donor lifetimes) are achieved in cells where the mVenus-BZip domain
is in excess so that the maximum number of mTurquoise-BZip domain proteins is paired
with the acceptor-labeled protein. A further increase in the mVenus-BZip domain proteins
will not change FRET efficiency. The data are fitted by a nonlinear regression for saturation
binding intersecting zero, since without the acceptor there can be no FRET (i.e., the
unquenched donor). The results in Fig. 3D demonstrate that the EFRET for the BZip protein
interaction plateaus at high IA/ID ratios.
3.4. Measuring heterologous protein interactions in living cells using FRET-FLIM
The heterochromatin protein 1 (HP1) family proteins are highly conserved non-histone
proteins that recognize the methylated lysine 9 of histone H3 [30, 31]. While the role of the
HP1 proteins in directing the assembly and maintenance of heterochromatin is well
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established, it has become increasingly clear that HP1 also plays roles in the regulation of
gene expression [32]. In this regard, the interactions between HP1α and C/EBPα, a
transcription factor involved in the control of cellular differentiation [25] is of significant
interest. In earlier studies, we demonstrated that HP1α and C/EBPα interact when the
proteins are bound to heterochromatin [33], and that only the BZip domain of C/EBPα was
necessary for the interaction with HP1α [34]. Here, the FRET-FLIM approach is used to
quantify the heterologous protein interactions between BZip domain of C/EBPα and HP1α.
First, the lifetime for the BZip domain labeled with Turquoise was determined in regions of
heterochromatin (typically five to ten ROI per cell nucleus) for ten different cells, yielding
an average unquenched donor lifetime of 3.89 ± 0.08 ns. Then intensity images and lifetime
measurements were made from cells co-producing the mTurquoise-BZip domain proteins
and Venus-HP1α (Fig. 4A). As a control for non-specific signals, measurements were also
made from cells producing the mTurquoiseN1 protein (localized in both cytoplasm and
nucleus) and Venus-HP1α (nuclear, see Fig. 4B). The lifetime map in Fig. 4B demonstrates
the quenched lifetimes of the Turquoise-BZip domain co-expressed with the Venus-labeled
HP1α, indicated by cooler colors on the LUT. In contrast, the lifetime of the TurquoiseN1
protein was not changed when co-expressed with Venus-HP1α (Fig. 4B, 4C). The EFRET
was then determined for cell co-producing mTurquoise-BZip domain proteins and Venus-
HP1α with different IA/ID ratios (Fig. 4C). This result clearly shows that the BZip domain of
C/EBPα is sufficient for the interaction with HP1α. To demonstrate that this dependence of
EFRET on the IA/ID ratio was not the result of background signals (such as crosstalk from the
acceptor) detected in the donor channel, the nuclear localized mVenus-HP1α was co-
produced with mTurquoiseN1 protein. Here, there was no trend toward increased EFRET
with increasing IA/ID ratio (Fig. 4C).
4. Concluding remarks
The relevance of the transient interactions between proteins inside living cells depends on
the context in which they occur. In this regard, the continued development of non-invasive
quantitative imaging techniques to visualize these protein interactions is critical for
understanding how networks of PPI form inside intact cells. While the high-throughput
approaches of yeast two-hybrid and co-affinity purification followed by mass spectrometry
do the heavy lifting for the mapping of interactomes, verification and fine-tuning is
necessary using many different types of cellular assays. The non-invasive FRET-FLIM
imaging approach described here provides a quantitative approach to interrogate PPI in
living cells. The phasor plot analysis of the fluorescence lifetime of the fluorophores within
a specimen is a direct measurement that does not require fitting to determine the time decay
parameters of the separate components [15–19].
A limitation of the FRET-FLIM approach is the necessity of producing the exogenous
proteins of interest labeled with the FPs inside living cells. It is critical to verify that the FP-
labeled proteins retain the functions of the endogenous proteins. Furthermore, the
overexpression of some FP-labeled proteins may interfere with the cellular processes that
are to be measured. This is a general concern that is shared with many different types of
assays, and requires careful control experiments. The FPs described here have been
extensively modified through mutagenesis to optimize their characteristics for expression
and imaging in living cells. The many new FP probes are allowing non-invasive imaging
techniques to complement and extend the results that are obtained by the biochemical
analysis of the endogenous cellular proteins. Importantly, the measurements obtained from
proteins labeled with the FPs in the natural environment inside living cells provide the most
physiologically relevant information about protein behavior currently available.
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Fig. 1.
FLIM measurements of purified mTurquoise2 and mCerulean. (A) The Weber plot
demonstrates the analysis of the multi-frequency (10–140 MHz) measurements of phase
delay and modulation ratio obtained from the samples of purified mTurquoise2 and
mCerulean. (B) The composite phasor plot for the measurements of the lifetime distributions
for mTurquoise2 or mCerulean obtained at the frequency of 30 MHz. The analysis of the
distributions yields a single component lifetime of 4.5 ns for mTurquoise2, and a two-
component intensity-weighted average lifetime of 3.1 ns for mCerulean. (C) The composite
phasor plot for the measurements of the lifetime distributions for mixtures of mTurquoise2
and mCerulean obtained at the frequency of 30 MHz.
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Fig. 2.
The phasor plot analysis of the lifetimes determine for the Cerulean3 FRET standards
produced in living cells. (A) The phasor lifetime distribution and intensity image of a cell
expressing Cerulean3-5aa-Amber (unquenched donor). The lifetime distribution on the
phasor plot represents every pixel in the image, and the intensity-weighted average lifetime
of 3.96 ns was determined in the ROI indicated by the red box in the intensity image; the
calibration bar indicates 10 µm. (B) The phasor lifetime distribution and intensity image of a
cell expressing Cerulean3-TRAF-Venus. The average lifetime of 3.68 ns was determined in
the indicated ROI. (C) The phasor lifetime distribution and intensity image of a cell
expressing Cerulean3-5aa-Venus. The amplitude-weighted average lifetime of 2.36 ns was
determined in the indicated ROI.
Day Page 12
Methods. Author manuscript; available in PMC 2015 March 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 3.
FRET-FLIM analysis of the homologous interactions between C/EBPα BZip domain
proteins. (A) A diagrammatic representation of the mTurquoise-labeled BZip (donor alone)
or the co-expressed mTurquoise-and mVenus-labeled BZip domain proteins (donor +
acceptor) bound to DNA as obligate dimers. (B) The intensity image from the donor channel
and the lifetime map for the nucleus of a cell expressing only the mTurquoise-BZip domain
(donor alone); the calibration bar indicates 10 µm. (C) The intensity images for the nucleus
of a cell expressing both the mTurquoise- and mVenus-BZip domain (donor + acceptor)
acquired in the acceptor channel, donor channel, and the lifetime map at an IA/ID ratio of
7.4. (D) FLIM was used to measure the donor lifetime in multiple ROI for each cell, and the
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FRET efficiency (%) was determined from the averaged donor lifetime using Eq. 1. The
results are plotted as a function of average IA/ID measured from each cell. Each point
represents the average EFRET (± SD) at the average IA/ID (± SD) for multiple ROI from an
individual cell.
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Fig. 4.
FRET-FLIM analysis of the heterologous interactions between the C/EBPα BZip domain
and HP1α. (A) The intensity images for the nucleus of a cell expressing both the
mTurquoise-BZip domain and mVenus-HP1α acquired in the acceptor channel, donor
channel (the calibration bar indicates 10 µm), and the corresponding lifetime map for the cell
with an IA/ID ratio of 31. (B) The intensity images for a cell expressing both the
mTurquoiseN1 (localized throughout the cytoplasm and nucleus) and mVenus-HP1α
(nuclear) acquired in the acceptor channel, donor channel, and the corresponding lifetime
map for the cell with an IA/ID ratio of 8. (C) FLIM was used to measure the donor lifetime
in multiple ROI for each cell, and the FRET efficiency (%) was determined. Each point
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represents the average EFRET (± SD) at the average IA/ID (± SD) for multiple cells
expressing the indicated donor- and acceptor-labeled proteins.
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Table 1
FD FLIM analysis of the purified protein variants of Cerulean.
Fluorescent
Proteina
2-component lifetime
(Fraction) b
Tau(f)c
(± SD)
R0 Venusd
(Å)
Cerulean 2.1 ns (0.66)
4.8 ns (0.34)
3.1 ± 0.03 50
Cerulean3 4.0 ns (0.99) 4.0 ± 0.02 54
Turquoise 4.1 ns (0.99) 4.1 ± 0.01 55
Turquoise2 4.4 ns (0.99) 4.4 ± 0.04 56
a
Purified proteins, n = 3.
b
Measurements were made at 12 frequencies from 10 to 120 MHz.
c
Tau(f) is the intensity-weighted average lifetime.
d
Förster distance determined by: R0 = 0.211 [(κ2)(n−4) (QYD) (Jλ)]1/6
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Table 2
FD FLIM analysis of mixtures of the purified Cerulean and Turquoise2.
Fluorescent
Protein mixturea
2-component lifetime
(Fraction) b
Tau(f)c
(± SD)
Cerulean (100) 2.5 ns (0.65)
3.2
Turquoise2 (0) 4.7 ns (0.35)
Cerulean (75) 3.2 ns d (0.76)
3.4
Turquoise2 (25) 4.6 ns (0.23)
Cerulean (50) 3.2 ns d (0.51)
3.8
Turquoise2 (50) 4.6 ns (0.49)
Cerulean (25) 3.2 ns d (0.24)
4.2
Turquoise2 (75) 4.6 ns (0.76)
Turquoise2 (0) 4.6 ns (1) 4.6
a
Mixed at indicated ratio to yield 105 counts in 300 µL PBS, n = 1.
b
Measurements were made at 12 frequencies from 10 to 120 MHz.
c
Tau(f) is the intensity-weighted average lifetime.
d
Lifetimes fixed, fraction unconstrained.
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